Waveforms/logfiles

  1. Chorpenning K, Brown MC, Vaskoboynikov N, Reyes C, Dierlam AE, Tamez D. HeartWare controller logs a diagnostic tool and clinical management aid for the HVAD pump. ASAIO J. 2014;60:115–8.
  2. Rich JD, Burkhoff D. HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J. 2017;63:526–35. 
  3. Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system: a novel approach using log file analysis. JACC Heart Fail. 2015;3:849–56.

Patient management (e.g., consensus doc, anticoagulation, blood pressure management)

  1. Hayward C, Adachi I, Baudart S, et al. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022;164:1120-37.
  2. Macaluso GP, Pagani FD, Slaughter MS, et al. Time in therapeutic range significantly impacts survival and adverse events in destination therapy patients. ASAIO J. 2022;68:14-20. 
  3. Milano CA, Rogers JG, Tatooles AJ, et al. HVAD: The ENDURANCE supplemental trial. JACC Heart Fail. 2018;6:792-802.
  4. Li S, Beckman JA, Wiederspan L, et al. First-in-man use of a modified controller to resolve HVAD failure-to-restart. ASAIO J. 2023;69:e409–10.

STS analyses (e.g., Intermacs quarterly analysis, HVAD™ to HeartMate 3 exchange)

  1. Song L, Slaughter MS, Hall Shelley, et al. Intermacs quarterly report analysis to monitor longitudinal outcomes in a centrifugal flow assist device. J Heart Lung Transplant. 2023;42:1510–4. 
  2. Cogswell R, Cantor RS, Vorovich E, et al. HVAD to HeartMate 3 device exchange: a society of thoracic surgeons intermacs analysis. Ann Thorac Surg. 2022;114:1672–8.
  3. Salerno CT, Jorde UP, Molina E, Cantor R, Pagani FD, Kirklin J.  Elective HeartWare HVAD to HeartMate 3 pump exchange: risk mitigation or increasing risk? [subscription required]. Ann Thorac Surg. 2022;113:438-440.